Mutation based approaches to the treatment of anaplastic thyroid cancer
Hilary C. McCrary(University of Utah), Dev Abraham(University of Utah), Joni Aoki(University of Utah), Yiqing Huang(First Affiliated Hospital of GuangXi Medical University), Benjamin L. Witt(NorthShore University HealthSystem), Barbara Chadwick(University of Utah), Jason P. Hunt(University of Utah), Katie Kerrigan(University of Utah)
Cited by 26
Related Papers
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|607
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|507
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018
|Journal of the National Comprehensive Cancer Network|2018|370
The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment
|Immunity|2018|216
Thyroid Carcinoma, Version 2.2014
|Journal of the National Comprehensive Cancer Network|2014|200